Carlos Solano
Carlos Solano is an expert in Hematology at Hospital Clínico Universitario de Valencia (Spain). As of October 2026, ScienceLeadR ranks Carlos Solano in the top 1% of experts worldwide for Stem Cell Transplantation and Cell Transplantation, and in the top 1% of experts in Spain for Graft vs Host Disease. Carlos Solano has authored 433 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 2 of them ongoing. SLR score: 1,507 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Transplantation - Infectiology - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 433
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results. PMID 42844290 — calcineurin, incidence, neutrophils, recycling, tacrolimus, cyclosporine, calcineurin inhibitors, graft vs host disease, transplants, therapeutics, blood platelets, infections | Bone Marrow Transplant | 2026 | 0 |
| Hypophosphatemia after CAR-T cell therapy: a prospective study of inflammation, tubular injury and phosphate handling. PMID 42840466 — cells, creatinine, hypophosphatemia, therapeutics, t-lymphocytes, prospective studies, receptors, antigen, t-cell, car-t cell | Clin Kidney J | 2026 | 0 |
| GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis. PMID 42754641 — cells, microscopy, electron, scanning transmission, incidence, stem cells, transplants, transplantation | Bone Marrow Transplant | 2026 | 0 |
| Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. PMID 42738255 — cells, microscopy, electron, scanning transmission, killer cells, natural, phenotype, cytomegalovirus, immunotherapy, immunotherapy, adoptive, transplants, therapeutics | Cancers (Basel) | 2026 | 0 |
| Magnusiomyces Capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Structured Review of the Literature. PMID 42730407 — cells, mortality, hematologic neoplasms, neutropenia, echinocandins, transplants, therapeutics, transplantation, infections, breakthrough infections | Mediterr J Hematol Infect Dis | 2026 | 0 |
Clinical Studies 17
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant NCT05982275 — neoplasms, plasma cell, cells, growth, microscopy, electron, scanning transmission, lymphocytes, pharmaceutical preparations, plasma cells, neoplasms, drugs, investigational, stem cells, multiple myeloma, receptors, antigen, receptors, growth factor, b-cell maturation antigen, receptors, chimeric antigen, transplants, therapeutics, cell transplantation, stem cell transplantation, t-lymphocytes, endothelial growth factors, b-lymphocytes, allografts, transplantation, plasma, receptors, antigen, t-cell | Phase 1/Phase 2 | Not yet recruiting | 2024 |
| Treatment Of Steroid Refractory Acute Graft versus host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy NCT04629833 — cells, microscopy, electron, scanning transmission, stem cells, mesenchymal stem cells, adolescent, everolimus, graft vs host disease, transplants, therapeutics, stromal cells, cell transplantation, stem cell transplantation, steroids, transplantation | Phase 3 | Recruiting | 2021 |
LeadR Networks
Main global connection map